Prescription eye drops recalled for particulate matter contamination
Sun Pharmaceutical recalls Xelpros latanoprost eye drops (Lot HAD3383A) due to particulate matter contamination detected during release testing. Affected bottles were distributed in Texas and Pennsylvania.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: This is an FDA Class III recall with no reported illnesses or injuries. The hazard—particulate matter detected in quality control testing—is theoretical, representing a contamination issue warranting a Moderate classification per the rubric guidance that Class III recalls are typically scored 1 or 2.
Plain-English summary
Xelpros (latanoprost ophthalmic emulsion) 0.005% is a prescription eye medication used to treat elevated eye pressure. Sun Pharmaceutical Industries Inc is recalling approximately 35,069 bottles with Lot number HAD3383A and expiration date August 31, 2024.
The recall was initiated following failed release testing, during which the medication was found to be out of specification for particulate matter. This indicates the presence of particles in the eye drop solution that should not be present.
The affected bottles were distributed in Texas and Pennsylvania. Patients currently using this medication should contact their healthcare provider or pharmacist to determine if they have a recalled bottle and discuss appropriate next steps.
The recalled product
- Product
- XELPROS (LATANOPROST)
- Brand
- XELPROS
- Manufacturer
- SUN PHARMACEUTICAL INDUSTRIES INC
- Category
- Drug — Ophthalmic
- Hazard
- particulate-matter
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot #: HAD3383A
- Exp 8/31/2024
Distribution
Distributed in 2 states:
- PA
- TX
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27
- LowPrimidone Tablets Recalled for Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27